An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection (Q40001995)
scientific article published on January 1, 1975
Language:
Current Data About An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection
(P31) (Q13442814)
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P304) 319-334
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P407) (Q1860)
(P248)
(P698) 181343
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=181343
(P813) Tuesday, May 24, 2022

(P433) 6
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P478) 5
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P577) Wednesday, January 1, 1975
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P921) (Q21014462)

(Q1016605)

(P953) https://www.karger.com/Article/Pdf/149930
(P248)
(P356) 10.1159/000149930
(P854) https://api.crossref.org/works/10.1159/000149930
(P813) Tuesday, May 24, 2022

(P1433) (Q15757002)
(P248)
(P698) 181343
(P813) Saturday, September 16, 2017

(P1476) "An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection" (language: en)
(P7452)
(P248)
(P356) 10.1159/000149930
(P854) https://api.crossref.org/works/10.1159/000149930
(P813) Tuesday, May 24, 2022

"An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection" (language: en)
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

(P2093) G. Klein
(P1545) 1
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

B. Giovanella
(P1545) 2
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

A. Westman
(P1545) 3
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

J. S. Stehlin
(P1545) 4
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

D. Mumford
(P1545) 5
(P248)
(P698) 181343
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A181343
(P813) Tuesday, May 24, 2022

(P4510) (Q54949198)

(Q54949201)

(Q54949204)

(Q54949206)

other details
description scientific article published on January 1, 1975

External Links
(P356) 10.1159/000149930
(P698) 181343
(P8608) release_dpirmumktbhfplg6bodpc52ese